These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 32586583

  • 1. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    Poole JE, Bahnson TD, Monahan KH, Johnson G, Rostami H, Silverstein AP, Al-Khalidi HR, Rosenberg Y, Mark DB, Lee KL, Packer DL, CABANA Investigators and ECG Rhythm Core Lab.
    J Am Coll Cardiol; 2020 Jun 30; 75(25):3105-3118. PubMed ID: 32586583
    [Abstract] [Full Text] [Related]

  • 2. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
    Monahan KH, Bunch TJ, Mark DB, Poole JE, Bahnson TD, Al-Khalidi HR, Silverstein AP, Daniels MR, Lee KL, Packer DL, CABANA Investigators.
    Europace; 2022 Oct 13; 24(9):1430-1440. PubMed ID: 35640922
    [Abstract] [Full Text] [Related]

  • 3. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, CABANA Investigators.
    JAMA; 2019 Apr 02; 321(13):1261-1274. PubMed ID: 30874766
    [Abstract] [Full Text] [Related]

  • 4. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.
    Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, Poole JE, Bahnson TD, Lee KL, Mark DB, CABANA Investigators.
    Circulation; 2021 Apr 06; 143(14):1377-1390. PubMed ID: 33554614
    [Abstract] [Full Text] [Related]

  • 5. Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.
    Bahnson TD, Giczewska A, Mark DB, Russo AM, Monahan KH, Al-Khalidi HR, Silverstein AP, Poole JE, Lee KL, Packer DL, CABANA Investigators.
    Circulation; 2022 Mar 15; 145(11):796-804. PubMed ID: 34933570
    [Abstract] [Full Text] [Related]

  • 6. Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.
    Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Moretz K, Poole JE, Mascette A, Rosenberg Y, Jeffries N, Al-Khalidi HR, Lee KL, CABANA Investigators.
    Am Heart J; 2018 May 15; 199():192-199. PubMed ID: 29754661
    [Abstract] [Full Text] [Related]

  • 7. Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial.
    Russo AM, Zeitler EP, Giczewska A, Silverstein AP, Al-Khalidi HR, Cha YM, Monahan KH, Bahnson TD, Mark DB, Packer DL, Poole JE, CABANA Investigators.
    Circulation; 2021 Feb 16; 143(7):661-672. PubMed ID: 33499668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fast atrial activity predicts recurrence of atrial fibrillation after pulmonary vein isolation: results from a prospective randomized study.
    Kriatselis C, Kaufmann J, Nedios S, Liu J, Gerds-Li JH, Fleck E.
    J Interv Card Electrophysiol; 2015 Mar 16; 42(2):101-6. PubMed ID: 25591723
    [Abstract] [Full Text] [Related]

  • 10. Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.
    Cappato R, Mark DB, Silverstein AP, Noseworthy PA, Bonitta G, Poole JE, Piccini JP, Bahnson TD, Daniels MR, Al-Khalidi HR, Lee KL, Packer DL, CABANA Investigators.
    Am Heart J; 2024 Apr 16; 270():103-116. PubMed ID: 38307365
    [Abstract] [Full Text] [Related]

  • 11. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, Lee KL, Packer DL, CABANA Investigators.
    JAMA; 2019 Apr 02; 321(13):1275-1285. PubMed ID: 30874716
    [Abstract] [Full Text] [Related]

  • 12. Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
    Thomas KL, Al-Khalidi HR, Silverstein AP, Monahan KH, Bahnson TD, Poole JE, Mark DB, Packer DL, CABANA Investigators.
    J Am Coll Cardiol; 2021 Jul 13; 78(2):126-138. PubMed ID: 34238436
    [Abstract] [Full Text] [Related]

  • 13. Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Chew DS, Li Y, Cowper PA, Anstrom KJ, Piccini JP, Poole JE, Daniels MR, Monahan KH, Davidson-Ray L, Bahnson TD, Al-Khalidi HR, Lee KL, Packer DL, Mark DB, CABANA Investigators.
    Circulation; 2022 Aug 16; 146(7):535-547. PubMed ID: 35726631
    [Abstract] [Full Text] [Related]

  • 14. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
    Pokushalov E, Romanov A, De Melis M, Artyomenko S, Baranova V, Losik D, Bairamova S, Karaskov A, Mittal S, Steinberg JS.
    Circ Arrhythm Electrophysiol; 2013 Aug 16; 6(4):754-60. PubMed ID: 23748210
    [Abstract] [Full Text] [Related]

  • 15. PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial.
    Duytschaever M, Demolder A, Phlips T, Sarkozy A, El Haddad M, Taghji P, Knecht S, Tavernier R, Vandekerckhove Y, De Potter T.
    Eur Heart J; 2018 Apr 21; 39(16):1429-1437. PubMed ID: 29211857
    [Abstract] [Full Text] [Related]

  • 16. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
    Cosedis Nielsen J, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS.
    N Engl J Med; 2012 Oct 25; 367(17):1587-95. PubMed ID: 23094720
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Nielsen JC, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Pehrson SM, Englund A, Hartikainen J, Mortensen LS, Hansen PS, MANTRA-PAF Investigators.
    Heart; 2017 Mar 25; 103(5):368-376. PubMed ID: 27566295
    [Abstract] [Full Text] [Related]

  • 18. Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation: A Secondary Analysis of a Randomized Clinical Trial.
    Andrade JG, Deyell MW, Verma A, Macle L, Champagne J, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Khairy P, Nattel S.
    JAMA Netw Open; 2020 Jul 01; 3(7):e208748. PubMed ID: 32614422
    [Abstract] [Full Text] [Related]

  • 19. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A, RAAFT-2 Investigators.
    JAMA; 2014 Feb 19; 311(7):692-700. PubMed ID: 24549549
    [Abstract] [Full Text] [Related]

  • 20. Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial.
    Castellá M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, Aragon D, Nuñez M, Sandoval E, Casellas A, Mont L, van Boven WJ, Boersma LVA, van Putte BP.
    Europace; 2019 May 01; 21(5):746-753. PubMed ID: 30715255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.